Even though no mutations of the calcium-sensing receptor gene have been found in parathyroid adenomas so far [17], the Arg990Gly polymorphism of this gene is important for calcimimetic pHPT therapy as a risk factor for nephrolithiasis. The gene discussed is CASR; the disease is nephrolithiasis.